End-of-day quote
Shanghai S.E.
06:00:00 2024-06-06 pm EDT
|
5-day change
|
1st Jan Change
|
13.97
CNY
|
+1.67%
|
|
-10.33%
|
-21.96%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,752
|
7,373
|
5,438
|
3,013
|
2,351
|
-
|
-
|
Enterprise Value (EV)
1 |
4,752
|
7,373
|
5,438
|
3,013
|
2,351
|
2,351
|
2,351
|
P/E ratio
|
36.3
x
|
57.4
x
|
83.9
x
|
33.1
x
|
20.1
x
|
15.7
x
|
13.2
x
|
Yield
|
-
|
0.54%
|
0.66%
|
1.12%
|
1.93%
|
1.11%
|
-
|
Capitalization / Revenue
|
-
|
21
x
|
12.5
x
|
6.76
x
|
4.4
x
|
3.46
x
|
3.31
x
|
EV / Revenue
|
-
|
21
x
|
12.5
x
|
6.76
x
|
4.4
x
|
3.46
x
|
3.31
x
|
EV / EBITDA
|
-
|
51.5
x
|
70
x
|
23.1
x
|
12.9
x
|
10.3
x
|
7.76
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
5.34
x
|
3.83
x
|
2.04
x
|
1.5
x
|
1.39
x
|
1.32
x
|
Nbr of stocks (in thousands)
|
168,000
|
168,000
|
168,000
|
168,309
|
168,309
|
-
|
-
|
Reference price
2 |
28.29
|
43.89
|
32.37
|
17.90
|
13.97
|
13.97
|
13.97
|
Announcement Date
|
2/21/21
|
2/27/22
|
2/27/23
|
2/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
351.1
|
433.4
|
445.5
|
534.8
|
680
|
711
|
EBITDA
1 |
-
|
143.2
|
77.7
|
130.4
|
183
|
227.2
|
303
|
EBIT
1 |
-
|
117.2
|
51.09
|
82.33
|
112.5
|
153.2
|
196
|
Operating Margin
|
-
|
33.37%
|
11.79%
|
18.48%
|
21.04%
|
22.53%
|
27.57%
|
Earnings before Tax (EBT)
1 |
-
|
152.1
|
78.14
|
101.4
|
128.2
|
166.8
|
196
|
Net income
1 |
130.7
|
128.6
|
64.37
|
91.52
|
117
|
149.4
|
179
|
Net margin
|
-
|
36.62%
|
14.85%
|
20.54%
|
21.88%
|
21.97%
|
25.18%
|
EPS
2 |
0.7786
|
0.7643
|
0.3857
|
0.5400
|
0.6967
|
0.8900
|
1.060
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.2357
|
0.2143
|
0.2000
|
0.2700
|
0.1550
|
-
|
Announcement Date
|
2/21/21
|
2/27/22
|
2/27/23
|
2/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q3
|
2022 Q4
|
---|
Net sales
1 |
-
|
160.2
|
EBITDA
|
-
|
-
|
EBIT
1 |
-
|
-20.02
|
Operating Margin
|
-
|
-12.5%
|
Earnings before Tax (EBT)
1 |
-
|
-9.697
|
Net income
1 |
27.84
|
-13.49
|
Net margin
|
-
|
-8.42%
|
EPS
|
0.1643
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
10/24/22
|
2/27/23
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
9.53%
|
4.61%
|
6.22%
|
7.52%
|
8.87%
|
10%
|
ROA (Net income/ Total Assets)
|
-
|
9.08%
|
4.21%
|
-
|
6.87%
|
7.87%
|
9.1%
|
Assets
1 |
-
|
1,416
|
1,530
|
-
|
1,704
|
1,899
|
1,967
|
Book Value Per Share
2 |
-
|
8.220
|
8.450
|
8.770
|
9.320
|
10.00
|
10.60
|
Cash Flow per Share
2 |
-
|
0.6100
|
1.050
|
0.4100
|
0.6200
|
0.5800
|
-
|
Capex
1 |
-
|
173
|
249
|
297
|
164
|
127
|
115
|
Capex / Sales
|
-
|
49.34%
|
57.52%
|
66.76%
|
30.57%
|
18.73%
|
16.17%
|
Announcement Date
|
2/21/21
|
2/27/22
|
2/27/23
|
2/23/24
|
-
|
-
|
-
|
Last Close Price
13.97
CNY Average target price
18.5
CNY Spread / Average Target +32.43% Consensus |
1st Jan change
|
Capi.
|
---|
| -21.96% | 324M | | +10.73% | 7.96B | | +5.95% | 7.66B | | -0.58% | 5.88B | | -6.11% | 3.72B | | -13.21% | 3.47B | | -15.49% | 1.16B | | -26.41% | 1.12B | | +9.98% | 948M | | -11.42% | 905M |
Special Foods & Wellbeing Products
|